SFDA Chief Calls for Strengthening International Regulatory Cooperation

CEO of the Saudi Food and Drug Authority Dr. Hisham Aljadhey underscored the importance of strengthening international cooperation between regulatory and supervisory bodies and harnessing innovation to develop regulatory frameworks, helping keep pace with rapid changes in the pharmaceutical sector and accelerate access to innovative treatments suited to patients' needs, particularly those with rare diseases and groups with special therapeutic needs.
His remarks came during his participation in a dialogue session titled "Shared Leadership: Shaping the Future of Global Regulatory Systems through Cooperation and Regulatory Innovation," as part of the DIA-MHRA Global Summit held by the Drug Information Association and the UK Medicines and Healthcare products Regulatory Agency in London on November 16 and 17.
The Kingdom continues to develop an integrated, sustainable model that enhances regulatory efficiency
He explained that under Saudi Vision 2030, the Kingdom continues to develop an integrated, sustainable regulatory model that enhances regulatory efficiency and its ability to anticipate challenges and adapt to change, placing patient protection at the top of its priorities by ensuring patients' access to safe and effective medical products that meet their health needs.
Aljadhey noted that the Kingdom's progress in the regulatory field resulted from integrated national efforts, investment in research and innovation, the use of emerging technologies in developing and manufacturing biologics, and the expansion of data infrastructure.
He added that these efforts have strengthened the health sector's capabilities and improved regulatory assessment tools, keeping pace with scientific and technical developments in the pharmaceutical industry and raising the efficiency of the regulatory system in dealing with rapid developments in the sector.
The authority's participation in the summit comes as an extension of its role in strengthening the Kingdom's presence at international regulatory forums and contributing to shaping the future direction of pharmaceutical regulation, through exchanging expertise and best practices with counterpart regulatory bodies and supporting innovation in medical product development, thereby enhancing patient safety and improving access to safe and effective treatments.
● Notice to (new) website visitors:You can subscribe to the news via WhatsApp for freeClick hereTo receive everything new and exclusive.Source akhbaar24